We are live on ! Find out more
SCM

Suvretta Capital Management Portfolio holdings

AUM $3.92B
1-Year Est. Return 86.67%
This Fund
S&P 500
This Quarter Est. Return
+13.45%
1 Year Est. Return
+86.67%
3 Year Est. Return
+295.96%
5 Year Est. Return
+364.48%
10 Year Est. Return
+2,073.65%
AUM
$3.13B
AUM Growth
+$403M
Cap. Flow
+$107M
Cap. Flow %
3.43%
Top 10 Hldgs %
44.51%
Holding
113
New
15
Increased
22
Reduced
19
Closed
15

Top Buys

Rank Stock Value
1
BNTC icon
Benitec Biopharma
BNTC
+$63.9M
2
SBUX icon
Starbucks
SBUX
+$47.2M
3
CRWD icon
CrowdStrike
CRWD
+$34.7M
4
COF icon
Capital One
COF
+$33.5M
5
BIOA
BioAge Labs
BIOA
+$29.2M

Top Sells

Rank Stock Value
1
INSM icon
Insmed
INSM
+$65.4M
2
ACLX
Arcellx
ACLX
+$55M
3
ELV icon
Elevance Health
ELV
+$49.5M
4
RARE icon
Ultragenyx Pharmaceutical
RARE
+$46.4M
5
SYY icon
Sysco
SYY
+$37.2M

Sector Composition

Rank Sector Weight
1 Healthcare 53.04%
2 Technology 9.98%
3 Consumer Discretionary 7.64%
4 Communication Services 6.42%
5 Financials 4.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AVBP icon
26
ArriVent BioPharma
AVBP
$1.44B
$43.4M 1.39%
1,845,162
+132,459
+8% +$3.01M
KO icon
27
Coca-Cola
KO
$375B
$42.3M 1.35%
588,912
+28,299
+5% +$1.94M
MSFT icon
28
Microsoft
MSFT
$3.71T
$41.5M 1.33%
96,526
-7,507
-7% -$3.21M
EYPT icon
29
EyePoint Inc
EYPT
$1.2B
$41.4M 1.32%
5,175,823
– –
ORCL icon
30
Oracle
ORCL
$423B
$40.4M 1.29%
237,094
-8,020
-3% -$1.16M
GE icon
31
GE Aerospace
GE
$384B
$37.8M 1.21%
200,662
-4,295
-2% -$728K
ERAS icon
32
Erasca
ERAS
$6.39B
$37.6M 1.2%
13,768,039
– –
COF icon
33
Capital One
COF
$134B
$35.3M 1.13%
+235,600
New +$33.5M
CRWD icon
34
CrowdStrike
CRWD
$218B
$34.3M 1.1%
+488,620
New +$34.7M
VZ icon
35
Verizon
VZ
$196B
$34.1M 1.09%
758,674
+148,770
+24% +$6.21M
CTNM
36
Contineum Therapeutics
CTNM
$566M
$32.9M 1.05%
1,720,000
-333,334
-16% -$6.39M
MCD icon
37
McDonald's
MCD
$195B
$31.6M 1.01%
103,638
-6,796
-6% -$1.87M
BIOA
38
BioAge Labs
BIOA
$538M
$30.3M 0.97%
+1,455,000
New +$29.2M
KDP icon
39
Keurig Dr Pepper
KDP
$40.8B
$26.4M 0.84%
+703,095
New +$24.7M
STRO icon
40
Sutro Biopharma
STRO
$421M
$24.9M 0.8%
718,750
-52,119
-7% -$2.04M
LVS icon
41
Las Vegas Sands
LVS
$29.6B
$24.4M 0.78%
+484,110
New +$19.8M
PROK icon
42
ProKidney
PROK
$337M
$23.7M 0.76%
12,341,266
+3,000,000
+32% +$6.81M
INTC icon
43
CALL
Intel
INTC
$513B
$23.5M 0.75%
+1,000,000
New +$25M
ABEO icon
44
Abeona Therapeutics
ABEO
$413M
$23.3M 0.75%
3,685,503
– –
JNJ icon
45
Johnson & Johnson
JNJ
$625B
$22.4M 0.72%
138,447
+48,350
+54% +$7.7M
BSX icon
46
Boston Scientific
BSX
$71.5B
$21.1M 0.67%
251,689
– –
PINS icon
47
Pinterest
PINS
$13.4B
$19.9M 0.64%
615,911
+205,960
+50% +$7M
ZURA icon
48
Zura Bio
ZURA
$566M
$19.7M 0.63%
4,860,939
– –
PEPG icon
49
PepGen
PEPG
$197M
$14.2M 0.45%
1,660,932
+140,000
+9% +$1.66M
GLUE icon
50
Monte Rosa Therapeutics
GLUE
$1.34B
$14.1M 0.45%
2,659,000
– –
1
2
3 4 5

Similar funds

MIM
Meridiem Investment Management London, United Kingdom $3.92B AUM 1.64% 1-Year Est. Return
BCP
BSN Capital Partners London, United Kingdom $3.93B AUM 13.09% 1-Year Est. Return
AS
American Securities New York $3.93B AUM 52.22% 1-Year Est. Return
MSI
Mitsui Sumitomo Insurance Tokyo, Japan $3.9B AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
LWCA
Locust Wood Capital Advisers New York $3.95B AUM 33.1% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return

Suvretta Capital Management's Q3 2024 Portfolio in Review

As of Q3 2024, Suvretta Capital Management held 113 positions worth $3.13B, up 15% from $2.72B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Suvretta Capital Management deployed $107M of net new capital in Q3 2024, opening 15 new positions and adding to 22 existing holdings. Its largest new stake was Starbucks: 550,309 shares worth $53.6M.

By sector, the portfolio is most concentrated in Healthcare at 53% of assets, down from 59% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Insmed, an estimated $65.4M trimmed.

  • Suvretta Capital Management's largest Q3 2024 buy was Starbucks: 550,309 shares worth $53.6M.
  • Suvretta Capital Management added most to Benitec Biopharma in Q3 2024, an estimated $63.9M increase.
  • Suvretta Capital Management's biggest Q3 2024 reduction was Insmed, cutting an estimated $65.4M.
  • Suvretta Capital Management fully exited Elevance Health in Q3 2024, selling an estimated $49.5M.
  • Suvretta Capital Management's ten largest holdings make up 45% of its $3.13B portfolio in Q3 2024.
  • Suvretta Capital Management opened 15 new positions and closed 15 in Q3 2024.
  • Suvretta Capital Management's portfolio value rose 15% quarter-over-quarter to $3.13B.

Based on Suvretta Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.